ArisGlobal , an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, announced five significant new product offerings to enable cross-functional AI operationalization. On the first day of Breakthrough 2026 , its annual industry event, the company unveiled XDI , its next-generation data intelligence cortex, three new AI agents , and NavaX Translation for data intake workflows in pharmacovigilance.
XDI – Explainable AI and evidence alignment across functional boundaries
XDI is ArisGlobal’s next-generation data intelligence cortex that can access data from multiple functions and systems to enable consistent and explainable decisions within and across the pharmaceutical R&D enterprise. Unlike tools that simply accelerate steps in a single workflow, XDI creates a system-agnostic foundation that unifies meaning, context, and intent—ensuring that decisions across safety, regulatory, clinical, quality, manufacturing, and all other functions are based on shared meaning, aligned evidence, and consistent governance. This will foster confident AI adoption and operationalization while reducing risk and interpretation drift between teams and use cases.
New agents for regulatory intelligence, change distribution, and signals
ArisGlobal has also expanded its NavaX Agents Suite portfolio with three new powerful agents:
- Intelligence Agents transforms the quality of submissions by automatically interpreting regulatory guidelines, converting them into accurate checklists, and evaluating LifeSphere Submissions files with clear compliance assessments, justifications, and confidence ratings.
- Distribution Agents ensures continuous validation of compliance by automatically consuming evolving regulatory directives, validating them against internal distribution logic, and triggering governed change workflows when discrepancies arise.
- Signals Agents is an intelligent assistant that interprets user intent, determines the best analytical approach, and dynamically plans and executes workflows. An active intelligence partner, it leverages a reasoning-based orchestration layer that encompasses security, data, analytics, and expert judgment.
NavaX Translation – Transforming case data intake workflows globally
ArisGlobal now offers certified translation capabilities integrated directly into data intake workflows, thanks to a strategic partnership with TransPerfect Life Sciences . Intelligent language detection instantly routes safety forms not written in English for translation using industry-specific language models and expert linguists. Seamless API integration returns translated forms directly to LifeSphere, eliminating manual effort and significantly accelerating pharmacovigilance globally. By combining NavaX and TransPerfect, translation management time is reduced from approximately five hours per case to less than one minute, delivering unparalleled automation, speed, and accuracy.
“The challenge for life sciences is not just to adopt AI – it’s to operationalize it at scale with consistency, governance, and real business impact. With these latest enhancements, we continue to enable organizations to move from experimentation to production, making AI a reliable basis for enterprise decision-making,” commented Aman Wasan, CEO of ArisGlobal.
Also Read: Modella AI Acquired by AstraZeneca to Scale AI Oncology R&D
“We are witnessing a fundamental shift in how technology enables life sciences teams to operate. These innovations represent the evolution from automating individual tasks to orchestrating intelligence across entire operational ecosystems , enabling smarter decisions, faster insights, and truly scalable AI adoption,” said Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.
Breakthrough 2026, held in Madrid, Spain, brings together senior executives, industry leaders and experts to explore the theme of “Operationalizing AI”, showing how proven AI use cases are becoming everyday practices in the life sciences.
Source: PRNewswire
